Use the Back button in your browser to see the other results of your search or to select another record.
A walk-and-eat intervention improves outcomes for patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy [with consumer summary] |
Xu Y-J, Cheng JC-H, Lee J-M, Huang P-M, Huang G-H, Chen CC-H |
The Oncologist 2015 Oct;20(10):1216-1222 |
clinical trial |
5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|